Clinical Trial Update: TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Johns Hopkins All Children's Hospital is evaluating TCR alpha-beta T-cell-depleted haploidentical hematopoietic cell transplantation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Bone Marrow Failure Syndrome
• Hemoglobinopathy

Snippet

Sponsor: Johns Hopkins All Children's Hospital | Conditions: Hemoglobinopathy (Disorder), Severe Aplastic Anemia | Phase 2 | Status: RECRUITING